Novartis

Conatus and Novartis suffer another midphase NASH flop
Fierce Biotech
Fri, 03/22/19 - 11:51 am
Conatus
Novartis
NASH
emricasan
clinical trials
Novartis says listing of Alcon eye care business expected on April 9
Yahoo/Reuters
Fri, 03/22/19 - 10:04 am
Alcon
Novartis
spinoffs
eye health
Novartis’ Alcon picks up PowerVision for $285m
Mass Device
Mon, 03/18/19 - 05:09 pm
Novartis
Alcon
PowerVision
M&A
interocular lens
devices
American College of Cardiology Conference Roundup - day 1
CP Wire
Sun, 03/17/19 - 01:25 pm
American College of Cardiology
Novartis
Entresto
heart failure
Edwards Lifesciences
Apple
TAVR
wearables
clinical trials
Apple Watch
atrial fibrillation
American College of Cardiology Conference Roundup - day 1
Sun, 03/17/19 - 01:24 pm
American College of Cardiology
Novartis
Entresto
heart failure
Edwards Lifesciences
Apple
TAVR
wearables
clinical trials
Apple Watch
atrial fibrillation
CEO of Novartis’ generics unit quits, sparking sale speculation
Pharmaforum
Thu, 03/14/19 - 10:06 am
Novartis
Sandoz
generics
M&A
Richard Francis
biosimilars
New insights emerge in an effort to repurpose Novartis’ cancer drug Tasigna in Parkinson’s disease
Fierce Biotech
Wed, 03/13/19 - 04:36 pm
Novartis
Tasigna
Parkinson's Disease
How This Looming Patent Battle Could Challenge Bristol-Celgene Deal
Investors Business Daily
Wed, 03/13/19 - 10:13 am
Celgene
Novartis
ozanimod
MS
multiple sclerosis
patents
Bristol-Myers Squibb
M&A
Novartis data confirm rapid response and high efficacy of Cosentyx in psoriasis patients for first time in China
Pharmaceutical Business Review
Tue, 03/5/19 - 10:00 am
Novartis
Cosentyx
China
psoriasis
Seventure holds first close of €200M microbiome fund
Fierce Biotech
Tue, 03/5/19 - 09:59 am
Seventure Partners
microbiome
Novartis
startups
Novartis Sues Janssen Over False Advertisements for Psoriasis Drug
RAPS.org
Mon, 03/4/19 - 12:08 pm
Novartis
Janssen
JNJ
psoriasis
false advertising
Tremfya
Johnson & Johnson keeps the heat on Tremfya's rivals with at-home injector nod
Fierce Pharma
Fri, 03/1/19 - 11:56 am
JNJ
Janssen
Tremfya
psoriasis
Novartis
Cosentyx
Eli Lilly
Taltz
Novartis faces shareholder criticism over drug prices at AGM
Yahoo/Reuters
Thu, 02/28/19 - 09:53 am
Novartis
drug pricing
shareholders
Novartis first partner in RWE collaboration for dermatology
BioCentury
Wed, 02/27/19 - 07:44 pm
Novartis
PharmaSolutions
real world evidence
dermatology
For Novartis, the Michael Cohen affair just won’t stay dead
Stat
Wed, 02/27/19 - 07:13 pm
Novartis
Donald Trump
Michael Cohen
Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Cardiovascular Disease Treatments
CP Wire
Wed, 02/27/19 - 10:52 am
Blackstone Life Sciences
Anthos Therapeutics
Novartis
MAA868
thromboembolism
Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Cardiovascular Disease Treatments
Wed, 02/27/19 - 10:14 am
Blackstone Life Sciences
Anthos Therapeutics
Novartis
MAA868
thromboembolism
Novartis socked with $1.5M whistleblower verdict
NJ Biz
Tue, 02/26/19 - 06:15 pm
Novartis
whistleblower lawsuits
Afinitor
kickbacks
Novartis aims to pump up cardio business with Ionis deal
Yahoo/Reuters
Mon, 02/25/19 - 09:51 am
Novartis
Ionis Pharmaceuticals
TQJ230
ICER's life year calculation gives Novartis wider pricing ballpark for SMA therapy
BioCentury
Sat, 02/23/19 - 04:36 pm
Novartis
Zolgensma
AVXS-101
spinal muscular atrophy
ICER

Pages